CCR1 and CCR5 promote hepatic fibrosis in mice
- 15 June 2009
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 119 (7), 1858-1870
- https://doi.org/10.1172/jci37444
Abstract
Hepatic fibrosis develops as a response to chronic liver injury and almost exclusively occurs in a proinflammatory environment. However, the role of inflammatory mediators in fibrogenic responses of the liver is only poorly understood. We therefore investigated the role of CC chemokines and their receptors in hepatic fibrogenesis. The CC chemokines MIP-1α, MIP-1β, and RANTES and their receptors CCR1 and CCR5 were strongly upregulated in 2 experimental mouse models of fibrogenesis. Neutralization of CC chemokines by the broad-spectrum CC chemokine inhibitor 35k efficiently reduced hepatic fibrosis, and CCR1- and CCR5-deficient mice displayed substantially reduced hepatic fibrosis and macrophage infiltration. Analysis of fibrogenesis in CCR1- and CCR5-chimeric mice revealed that CCR1 mediates its profibrogenic effects in BM-derived cells, whereas CCR5 mediates its profibrogenic effects in resident liver cells. CCR5 promoted hepatic stellate cell (HSC) migration through a redox-sensitive, PI3K-dependent pathway. Both CCR5-deficient HSCs and CCR1- and CCR5-deficient Kupffer cells displayed strong suppression of CC chemokine–induced migration. Finally, we detected marked upregulation of RANTES, CCR1, and CCR5 in patients with hepatic cirrhosis, confirming activation of the CC chemokine system in human fibrogenesis. Our data therefore support a role for the CC chemokine system in hepatic fibrogenesis and suggest distinct roles for CCR1 and CCR5 in Kupffer cells and HSCs.Keywords
This publication has 57 references indexed in Scilit:
- Dual Role of CCR2 in the Constitution and the Resolution of Liver Fibrosis in MiceThe American Journal of Pathology, 2009
- CCR2 promotes hepatic fibrosis in miceJournal of Hepatology, 2009
- Targeting Chemokine Receptors in HIV: A Status ReportAnnual Review of Pharmacology and Toxicology, 2008
- TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouseJournal of Hepatology, 2008
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the LiverPhysiological Reviews, 2008
- Essential Roles of the CC Chemokine Ligand 3-CC Chemokine Receptor 5 Axis in Bleomycin-Induced Pulmonary Fibrosis through Regulation of Macrophage and Fibrocyte InfiltrationThe American Journal of Pathology, 2007
- Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosisJournal of Hepatology, 2006
- A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populationsJournal of Hepatology, 2004
- Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infectionJournal of Hepatology, 2003
- Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosisThe Journal of Pathology, 1998